Cellectis Valuation
| ALCLS Stock | EUR 3.11 0.05 1.58% |
At this time, the firm appears to be overvalued. Cellectis shows a prevailing Real Value of €2.91 per share. The current price of the firm is €3.11. Our model approximates the value of Cellectis from analyzing the firm fundamentals such as Profit Margin of (0.43) %, current valuation of 228.76 M, and Return On Equity of -0.31 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cellectis' valuation include:
Price Book 3.6511 | Enterprise Value | Enterprise Value Ebitda (3.44) | Price Sales 3.7735 | Enterprise Value Revenue 3.5792 |
Overvalued
Today
Please note that Cellectis' price fluctuation is very risky at this time. Calculation of the real value of Cellectis is based on 3 months time horizon. Increasing Cellectis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Cellectis' intrinsic value may or may not be the same as its current market price of 3.11, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.11 | Real 2.91 | Hype 3.08 |
The intrinsic value of Cellectis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cellectis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cellectis helps investors to forecast how Cellectis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellectis more accurately as focusing exclusively on Cellectis' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cellectis' intrinsic value based on its ongoing forecasts of Cellectis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cellectis' closest peers.
Cellectis Cash |
|
Cellectis Total Value Analysis
Cellectis is presently projected to have takeover price of 228.76 M with market capitalization of 311.51 M, debt of 91.46 M, and cash on hands of 110.34 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cellectis fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
228.76 M | 311.51 M | 91.46 M | 110.34 M |
Cellectis Investor Information
About 48.0% of the company shares are held by company insiders. The book value of Cellectis was presently reported as 1.17. The company recorded a loss per share of 0.28. Cellectis had not issued any dividends in recent years. The entity had 2:1 split on the 1st of November 2011. Based on the key indicators related to Cellectis' liquidity, profitability, solvency, and operating efficiency, Cellectis is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Cellectis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cellectis has an asset utilization ratio of 10.82 percent. This connotes that the Company is making €0.11 for each dollar of assets. An increasing asset utilization means that Cellectis is more efficient with each dollar of assets it utilizes for everyday operations.Cellectis Profitability Analysis
Based on Cellectis' profitability indicators, Cellectis may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Cellectis' ability to earn profits and add value for shareholders.Net Loss | First Reported 2012-09-30 | Previous Quarter -23.7 M | Current Value 589 K | Quarterly Volatility 14.9 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.026 | 0.0274 |
|
|
For Cellectis profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cellectis to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cellectis utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cellectis's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cellectis over time as well as its relative position and ranking within its peers.
Cellectis Earnings per Share Projection vs Actual
By analyzing Cellectis' earnings estimates, investors can diagnose different trends across Cellectis' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Cellectis is based on EPS before non-recurring items and includes expenses related to employee stock options.Cellectis Ownership Allocation
Cellectis holds a total of 72.33 Million outstanding shares. Cellectis retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cellectis Profitability Analysis
The company reported the revenue of 41.51 M. Net Loss for the year was (36.76 M) with profit before overhead, payroll, taxes, and interest of 82.55 M.About Cellectis Valuation
The stock valuation mechanism determines Cellectis' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Cellectis based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cellectis. We calculate exposure to Cellectis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cellectis's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 47.7 M | 24.5 M | |
| Pretax Profit Margin | (1.02) | (1.07) | |
| Operating Profit Margin | (1.65) | (1.73) | |
| Net Loss | (1.02) | (1.07) | |
| Gross Profit Margin | 0.03 | 0.03 |
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.